First-Mover Advantage: Why Being First to Market Matters for Generic Drug Manufacturers
Discover why being the first generic manufacturer matters. Learn how the Hatch-Waxman Act's 180-day exclusivity creates lasting market share dominance through prescriber habits and pharmacy inertia.